InvestorsHub Logo
Followers 0
Posts 46
Boards Moderated 0
Alias Born 10/22/2006

Re: None

Tuesday, 05/15/2012 10:01:55 PM

Tuesday, May 15, 2012 10:01:55 PM

Post# of 2378
What do you think this is about?

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
April 17, 2012
ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Champions Oncology, Inc.
File No. 0-17263 - CF#28096
_____________________
Champions Oncology, Inc. submitted an application under Rule 24b-2 requesting
confidential treatment for information it excluded from the Exhibits to a Form 10-K filed
July 15, 2011, as amended on March 13, 2012.
Based on representations by Champions Oncology, Inc. that this information
qualifies as confidential commercial or financial information under the Freedom of
Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined
not to publicly disclose it. Accordingly, excluded information from the following
exhibit(s) will not be released to the public for the time period(s) specified:
Exhibit 10.3 through April 30, 2016
For the Commission, by the Division of Corporation Finance, pursuant to
delegated authority:
Jennifer Riegel
Special Counsel
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CSBR News